KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Current Liabilities: 2018-2025

Historic Total Current Liabilities for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $91.4 million.

  • Twist Bioscience's Total Current Liabilities rose 28.73% to $91.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.4 million, marking a year-over-year increase of 28.73%. This contributed to the annual value of $91.4 million for FY2025, which is 28.73% up from last year.
  • Latest data reveals that Twist Bioscience reported Total Current Liabilities of $91.4 million as of FY2025, which was up 28.73% from $71.0 million recorded in FY2024.
  • Twist Bioscience's 5-year Total Current Liabilities high stood at $91.4 million for FY2025, and its period low was $63.1 million during FY2021.
  • Its 3-year average for Total Current Liabilities is $78.6 million, with a median of $73.3 million in 2023.
  • As far as peak fluctuations go, Twist Bioscience's Total Current Liabilities skyrocketed by 75.00% in 2021, and later fell by 19.13% in 2023.
  • Yearly analysis of 5 years shows Twist Bioscience's Total Current Liabilities stood at $63.1 million in 2021, then skyrocketed by 43.79% to $90.7 million in 2022, then fell by 19.13% to $73.3 million in 2023, then declined by 3.16% to $71.0 million in 2024, then rose by 28.73% to $91.4 million in 2025.